REBLOZYL

Google image searchProduct monograph

Active ingredient

luspatercept, 25 MG/VIAL

DIN: 02505541

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: BRISTOL-MYERS SQUIBB CANADA

Date: 26-MAR-2024

ATC:

• B03 — ANTIANEMIC PREPARATIONS (ATC, ATC/DDD, )
• B03X — OTHER ANTIANEMIC PREPARATIONS (ATC, ATC/DDD)
• B03XA — Other antianemic preparations (ATC, ATC/DDD)
• B03XA06 — LUSPATERCEPT (ATC/DDD)

Reference brand drug: Reblozyl

External Links for Reblozyl

Search on Google

• Reblozyl side effects
• Reblozyl dosage
• luspatercept side effects
• luspatercept dosage

Bristol-Myers Squibb Canada

Go to Bristol-Myers Squibb website to see drug product details. Sometimes you can find reblozyl photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.